Victory!

Or something not as close to defeat.
The private equity consortium looking to buy Biomet (BMET) has increased its bid to $46 a share. The vote scheduled for this Friday has been canceled.

Posted by on June 7th, 2007 at 9:57 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.